WPRIM Management System> DCMS> Journal of Movement Disorders> 2022> 15

Volume: 15

1. Premonitory Urges Reconsidered: Urge Location Corresponds to Tic Location in Patients With Primary Tic Disorders Page:43—52
2. Extensive Leukoencephalopathy in Spastic Paraplegia Type 4: Possible Role of Cerebral Autosomal Arteriopathy With Subcortical Infarcts and Leukoencephelopathy Page:71—74
3. Current Status of Telemedicine for Parkinson’s Disease in Japan: A Single-Center Cross-Sectional Questionnaire Survey Page:58—61
4. Re: Comments on “Chorea as a Presentation of SARS-CoV-2 Encephalitis: A Clinical Case Report” Page:94—94
5. Comment on “Chorea as a Presentation of SARS-CoV-2 Encephalitis: A Clinical Case Report” Page:93—93
6. Parainfectious Anti-Glial Fibrillary Acidic Protein-Associated Meningoencephalitis Page:66—70
7. The Supplementary Motor Complex in Parkinson’s Disease Page:21—32
8. COVID-19 Associated Acute Necrotizing Encephalopathy Presenting as Parkinsonism and Myorhythmia Page:89—92
9. Constipation is Associated With Mild Cognitive Impairment in Patients With de novo Parkinson’s Disease Page:38—42
10. Association of AXIN1 With Parkinson’s Disease in a Taiwanese Population Page:33—37
11. Gene Therapy for Huntington’s Disease: The Final Strategy for a Cure? Page:15—20
12. Deep Brain Stimulation for Cockayne Syndrome-Associated Movement Disorder Page:62—65
13. Dance Intervention Using the Feldenkrais Method Improves Motor, and Non-Motor Symptoms and Gait in Parkinson’s Disease: A 12-Month Study Page:53—57
14. Evidence of Inflammation in Parkinson’s Disease and Its Contribution to Synucleinopathy Page:1—14
15. Task-Specific Dystonia in a Professional Billiard Player Page:86—88
16. Dancing Feet Dyskinesia in a Patient with GBA-PD Page:83—85
17. Opsoclonus-Myoclonus Syndrome as a Heralding Feature of Scrub Typhus: An Illustrative Case with a Video Vignette Page:80—82
18. Resilience and Trauma among Patients with Parkinson’s Disease during the COVID-19 Pandemic Page:77—79
19. Cortical Subarachnoid Hemorrhage Presenting with Hemibody Dystonic Myoclonus: An Illustrative Case Page:75—76
20. Re: Comment on “Parainfectious Anti-Glial Fibrillary Acidic Protein-Associated Meningoencephalitis” Page:189—189
21. Accuracy of Machine Learning Using the Montreal Cognitive Assessment for the Diagnosis of Cognitive Impairment in Parkinson’s Disease Page:132—139
22. Development of Clinical Milestones in Parkinson’s Disease After Bilateral Subthalamic Deep Brain Stimulation Page:124—131
23. Diagnosis and Clinical Features in Autoimmune-Mediated Movement Disorders Page:95—105
24. Acute Extrapyramidal Side Effects Following Domperidone Intake in a 48-Year-Old Female Patient: The First Genetic Alteration and Drug Interaction Characterized Page:193—195
25. Hand Movement-Induced Eyeblink Bursts in a Patient With Parkinson’s Disease Page:190—192
26. Comment on “Parainfectious Anti-Glial Fibrillary Acidic Protein-Associated Meningoencephalitis” Page:187—188
27. Pseudodystonia and Neuropathic Tremor in a Patient With Monomelic Amyotrophy Page:181—183
28. Effect of Chelation Therapy on a Korean Patient With Brain Manganese Deposition Resulting From a Compound Heterozygous Mutation in the SLC39A14 Gene Page:171—174
29. Expanding the Clinical Spectrum of RFC1 Gene Mutations Page:167—170
30. Umami and Other Taste Perceptions in Patients With Parkinson’s Disease Page:115—123
31. Asymmetric Parkinsonism With Progressive Nigrosomal Change Secondary to Kernohan’s Notch Phenomenon Page:184—186
32. Utility of Clinical Exome Sequencing in Dystonia: A Single-Center Study From India Page:156—161
33. Long-Term Outcome of Hemimasticatory Spasm Page:146—150
34. Automatic Measurement of Postural Abnormalities With a Pose Estimation Algorithm in Parkinson’s Disease Page:140—145
35. A Case of AOA2 With Compound Heterozygous SETX Mutations Page:178—180
36. Labrune’s Syndrome Presenting With Stereotypy-Like Movements and Psychosis: A Case Report and Review Page:162—166
37. Fecal Calprotectin in Parkinson’s Disease and Multiple System Atrophy Page:106—114
38. Syringomyelia Manifesting With Pseudodystonia: A Case Report Page:175—177
39. Presynaptic Dopaminergic Dysfunction Was Overestimated in Huntington’s Disease Presenting as Young Age-Onset Parkinsonism Page:293—295
40. Teaching Research Methods to Young Neurologists: The Erice International Courses Page:227—231
41. Potential Link Between Cognition and Motor Reserve in Patients With Parkinson’s Disease Page:249—257
42. Treatable Ataxias: How to Find the Needle in the Haystack? Page:206—226
43. Continuous 24-h Levodopa-Carbidopa Intestinal Gel Infusion After a Levodopa Holiday Suppressed Refractory Dyskinesia Despite Increasing Levodopa Dose Page:290—292
44. Multiple Sclerosis-Related Paroxysmal Kinesigenic Dyskinesia: Long Term, Favorable Response to Lacosamide Page:286—289
45. Blacksmith’s Dystonia Is Another Task-Specific Dystonia: From Past to Present Page:284—285
46. Nearly Abolished Dopamine Transporter Uptake in a Patient With a Novel FBXO7 Mutation Page:269—272
47. Sensitivity of Detecting Alpha-Synuclein Accumulation in the Gastrointestinal Tract and Tissue Volume Examined Page:264—268
48. Long-Term Outcomes of Deep Brain Stimulation in Pantothenate Kinase-Associated Neurodegeneration-Related Dystonia Page:241—248
49. Semiautomated Algorithm for the Diagnosis of Multiple System Atrophy With Predominant Parkinsonism Page:232—240
50. Pallidus Stimulation for Chorea-Acanthocytosis: A Systematic Review and Meta-Analysis of Individual Data Page:197—205
51. Refractory Myoclonus as a Presentation of Metabolic Stroke in A Child With Cobalamin B Methylmalonic Acidemia After Liver and Kidney Transplant Page:281—283
52. Movement Disorders Resulting From Bilateral Basal Ganglia Lesions in End-Stage Kidney Disease: A Systematic Review Page:258—263
53. Catatonia in Hospitalized Patients With COVID-19: An Important Clinical Finding That Should Not be Missed Page:277—280
54. Mosapride-Induced Movement Disorders Page:273—276